Arno Nolting

1.2k total citations
28 papers, 898 citations indexed

About

Arno Nolting is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Pharmacology. According to data from OpenAlex, Arno Nolting has authored 28 papers receiving a total of 898 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Pulmonary and Respiratory Medicine, 9 papers in Oncology and 8 papers in Pharmacology. Recurrent topics in Arno Nolting's work include Colorectal Cancer Treatments and Studies (7 papers), Lung Cancer Treatments and Mutations (6 papers) and Cancer Treatment and Pharmacology (5 papers). Arno Nolting is often cited by papers focused on Colorectal Cancer Treatments and Studies (7 papers), Lung Cancer Treatments and Mutations (6 papers) and Cancer Treatment and Pharmacology (5 papers). Arno Nolting collaborates with scholars based in United States, Germany and Japan. Arno Nolting's co-authors include Andreas Kovar, Teresa Dalla Costa, Kenneth H. Rand, Gunnar Folprecht, Manfred P. Lutz, Thomas Seufferlein, Patrick Schöffski, C.-H. Köhne, Wattanaporn Abramowitz and Hartmut Derendorf and has published in prestigious journals such as Journal of Clinical Oncology, Annals of Oncology and European Journal of Cancer.

In The Last Decade

Arno Nolting

27 papers receiving 851 citations

Peers

Arno Nolting
Val R. Adams United States
Benjamin Weber United States
Estelle Marrer Switzerland
Robert Shumaker United States
Arno Nolting
Citations per year, relative to Arno Nolting Arno Nolting (= 1×) peers Andreas Kovar

Countries citing papers authored by Arno Nolting

Since Specialization
Citations

This map shows the geographic impact of Arno Nolting's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Arno Nolting with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Arno Nolting more than expected).

Fields of papers citing papers by Arno Nolting

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Arno Nolting. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Arno Nolting. The network helps show where Arno Nolting may publish in the future.

Co-authorship network of co-authors of Arno Nolting

This figure shows the co-authorship network connecting the top 25 collaborators of Arno Nolting. A scholar is included among the top collaborators of Arno Nolting based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Arno Nolting. Arno Nolting is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
García‐Arieta, Alfredo, et al.. (2018). A Survey of the Regulatory Requirements for BCS-Based Biowaivers for Solid Oral Dosage Forms by Participating Regulators and Organisations of the International Generic Drug Regulators Programme. Journal of Pharmacy & Pharmaceutical Sciences. 21(1). 27–27. 14 indexed citations
2.
Shirao, Kuniaki, Takayuki Yoshino, Narikazu Boku, et al.. (2009). A phase I escalating single-dose and weekly fixed-dose study of cetuximab pharmacokinetics in Japanese patients with solid tumors. Cancer Chemotherapy and Pharmacology. 64(3). 557–564. 10 indexed citations
4.
Nolting, Arno, et al.. (2008). Population Pharmacokinetics of Cetuximab in Patients With Squamous Cell Carcinoma of the Head and Neck. The Journal of Clinical Pharmacology. 48(3). 267–278. 66 indexed citations
5.
Uhl, Wolfgang, Arno Nolting, Georg Golor, Karl Ludwig Rost, & Andreas Kovar. (2006). Safety of Hydroxocobalamin in Healthy Volunteers in a Randomized, Placebo-Controlled Study. Clinical Toxicology. 44(sup1). 17–28. 71 indexed citations
6.
Folprecht, Gunnar, Manfred P. Lutz, Patrick Schöffski, et al.. (2005). Cetuximab and irinotecan/5-fluorouracil/folinic acid is a safe combination for the first-line treatment of patients with epidermal growth factor receptor expressing metastatic colorectal carcinoma. Annals of Oncology. 17(3). 450–456. 192 indexed citations
7.
Delbaldo, Catherine, Jean‐Yves Pierga, Véronique Dièras, et al.. (2005). Pharmacokinetic profile of cetuximab (Erbitux™) alone and in combination with irinotecan in patients with advanced EGFR-positive adenocarcinoma. European Journal of Cancer. 41(12). 1739–1745. 71 indexed citations
8.
Roy, Partha Pratim, et al.. (2005). The single-dose pharmacokinetics of the novel CCK1 receptor antagonist, dexloxiglumide, are not influenced by age and gender. International Journal of Clinical Pharmacology and Therapeutics. 43(9). 444–451. 3 indexed citations
9.
Kapil, Ram P., Arno Nolting, Partha Pratim Roy, et al.. (2004). Pharmacokinetic properties of combination oxycodone plus racemic ibuprofen: Two randomized, open-label, crossover studies in healthy adult volunteers. Clinical Therapeutics. 26(12). 2015–2025. 19 indexed citations
10.
Nolting, Arno, et al.. (2002). Single‐dose study to compare the pharmacokinetics of HFA flunisolide and CFC flunisolide. Journal of Pharmaceutical Sciences. 91(2). 424–432. 9 indexed citations
11.
Nolting, Arno, et al.. (2002). Single-dose study to compare the pharmacokinetics of HFA flunisolide and CFC flunisolide. Journal of Pharmaceutical Sciences. 91(2). 424–424. 1 indexed citations
12.
Nolting, Arno, et al.. (2001). Flunisolide HFA vs flunisolide CFC: pharmacokinetic comparison in healthy volunteers. Biopharmaceutics & Drug Disposition. 22(9). 373–382. 10 indexed citations
13.
Hirst, Peter H., et al.. (2001). Deposition and Pharmacokinetics of Flunisolide Delivered from Pressurized Inhalers Containing Non-CFC and CFC Propellants. Journal of Aerosol Medicine. 14(2). 197–208. 54 indexed citations
14.
Nolting, Arno & Wattanaporn Abramowitz. (2000). Lack of Interaction Between Citalopram and the CYP3A4 Substrate Triazolam. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 20(7). 750–755. 11 indexed citations
15.
Costa, Teresa Dalla, et al.. (1998). Determination of free interstitial concentrations of piperacillin- tazobactam combinations by microdialysis. Journal of Antimicrobial Chemotherapy. 42(6). 769–778. 25 indexed citations
16.
DeLong, Robert K., Arno Nolting, M. H. FISHER, et al.. (1997). Comparative Pharmacokinetics, Tissue Distribution, and Tumor Accumulation of Phosphorothioate, Phosphorodithioate, and Methylphosphonate Oligonucleotides in Nude Mice. Antisense and Nucleic Acid Drug Development. 7(2). 71–77. 42 indexed citations
17.
Nolting, Arno, Robert K. DeLong, Michael H. Fisher, et al.. (1997). Hepatic Distribution and Clearance of Antisense Oligonucleotides in the Isolated Perfused Rat Liver. Pharmaceutical Research. 14(4). 516–521. 18 indexed citations
18.
DeLong, Robert K., Katherine Stephenson, Michael H. Fisher, et al.. (1997). Characterization of Complexes of Oligonucleotides with Polyamidoamine Starburst Dendrimers and Effects on Intracellular Delivery. Journal of Pharmaceutical Sciences. 86(6). 762–764. 111 indexed citations
19.
Nolting, Arno, Teresa Dalla Costa, Richard Vistelle, Kenneth H. Rand, & Hartmut Derendorf. (1996). Determination of Free Extracellular Concentrations of Piperacillin by Microdialysis. Journal of Pharmaceutical Sciences. 85(4). 369–372. 41 indexed citations
20.
Nolting, Arno, Teresa Dalla Costa, Kenneth H. Rand, & Hartmut Derendorf. (1996). Pharmacokinetic-Pharmacodynamic Modeling of the Antibiotic Effect of Piperacillin in Vitro. Pharmaceutical Research. 13(1). 91–96. 52 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026